BioSpace News Archive

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a growing pipeline, including Phase 2 clinical programs, for hard-to-treat cancers and viruses, provided an update on recent activity and expected near term milestones across its clinical development pipeline.

Sera Prognostics Inc., The Pregnancy Company®, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced financial results for the first quarter of 2023 ended March 31, 2023.

INOVIO (NASDAQ:INO) today announced financial results and operational highlights for the first quarter of 2023.

ChromaDex Corp. announced financial results for the first quarter of 2023.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2023, affirmed 2023 financial guidance and provided business updates.

Cyteir Therapeutics, Inc. (“Cyteir”) (Nasdaq: CYT), a clinical stage oncology company, today reported financial results for the first quarter ended March 31, 2023 and provided an update on recent operational highlights.

Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today provided financial results for the three months ended March 31, 2023, as well as a clinical and business update.

Nephros, Inc., a leading water technology company providing filtration solutions to the medical and commercial markets, announced financial results for the first quarter ended March 31, 2023.

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced financial results and a business update for the first quarter ended March 31, 2023.

Cue Health Inc., a healthcare technology company, reported financial results for the first quarter 2023.